What’s Next for Icad Inc (NASDAQ:ICAD) After Having Less Shares Shorted?


The stock of Icad Inc (NASDAQ:ICAD) registered a decrease of 17.8% in short interest. ICAD’s total short interest was 428,100 shares in September as published by FINRA. Its down 17.8% from 520,800 shares, reported previously. With 139,000 shares average volume, it will take short sellers 3 days to cover their ICAD’s short positions. The short interest to Icad Inc’s float is 3.07%.

The stock decreased 0.57% or $0.04 during the last trading session, reaching $6.94. About 40,171 shares traded. iCAD, Inc. (NASDAQ:ICAD) has risen 113.04% since September 13, 2018 and is uptrending. It has outperformed by 113.04% the S&P500.

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. The company has market cap of $133.68 million. It operates through two divisions, Cancer Detection and Cancer Therapy. It currently has negative earnings. The firm provides electronic brachytherapy products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy.

More notable recent iCAD, Inc. (NASDAQ:ICAD) news were published by: Globenewswire.com which released: “Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer – GlobeNewswire” on January 03, 2019, also Globenewswire.com with their article: “iCAD Appoints Stacey Stevens as President Nasdaq:ICAD – GlobeNewswire” published on March 28, 2019, Globenewswire.com published: “iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results – GlobeNewswire” on March 18, 2019. More interesting news about iCAD, Inc. (NASDAQ:ICAD) were released by: Globenewswire.com and their article: “Medical City Plano, a HCA Healthcare Facility, Adopts iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer – GlobeNewswire” published on August 28, 2018 as well as Globenewswire.com‘s news article titled: “iCAD Introduces ProFound AIâ„¢ for 2D Mammography in Europe – GlobeNewswire” with publication date: June 13, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.